Coombs, G. W., Daley, D. A., Shoby, P. & Mowlaboccus, S. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Surveillance Outcome – Program (ASSOP) Bloodstream Infection Annual Report 2022. Communicable Diseases Intelligence 47, (2023).
Abdulgader, S. M., van Rijswijk, A., Whitelaw, A. & Newton-Foot, M. The association between pathogen factors and clinical outcomes in patients with Staphylococcus aureus bacteraemia in a tertiary hospital, cape town. Int. J. Infect. Dis. 91, 111–118 (2020).
Kolben, Y. et al. Right-sided endocarditis caused by polyclonal Staphylococcus aureus infection. European J. Med. Research 26, 96 (2021).
Pacheco, R. L. et al. Methicillin-resistant Staphylococcus aureus (MRSA) carriage in a dermatology unit. Clinics 66, 2071–2077 (2011).
China, A., Resistance, Surveillance & System Antimicrobial resistance of bacteria: surveillance report from China Anti- microbial resistance surveillance system in 2014–2019. Chin. J. Infect. Control Vol. 20(1), 15–31 (2021).
Laupland, K. B. et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin. Microbiol. Infect. 19(5), 465–471 (2013).
Kaasch, A. J. et al. Staphylococcus aureus bloodstream infection: A pooled analysis of five prospective, observational studies. J. Infect. 68, 242–251 (2014).
Ikuta, K. S. et al. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019. Lancet 400, 2221–2248 (2022).
You, J. H. S. et al. Disease burden, characteristics, and outcomes of Methicillin-Resistant Staphylococcus aureus bloodstream infection in Hong Kong. Asia Pac. J. Public. Health. 29, 451–461 (2017).
Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).
Xie, Y. et al. 28-day sepsis mortality prediction model from combined serial interleukin-6, lactate, and procalcitonin measurements: a retrospective cohort study. Eur. J. Clin. Microbiol. Infect. Dis. 42, 77–85 (2022).
Sun, Y. et al. A nomogram for prediction of survival in patients after gastrectomy within enhanced recovery after surgery (ERAS): A Single-Center retrospective study. Med. Sci. Monit. 26, e926347 (2020).
Wei, J. et al. Nomogram predictive model for in-hospital mortality risk in elderly ICU patients with Urosepsis. BMC Infect. Dis. 24, 442 (2024).
Li, D. et al. A predictive nomogram for mortality of cancer patients with invasive candidiasis: a 10-year study in a cancer center of North China. BMC Infect. Dis. 21, 76 (2021).
Li, Z. et al. A predictive nomogram for surgical site infection in patients who received clean orthopedic surgery: a retrospective study. J. Orthop. Surg, Res. 19, 38 (2024).
Rac, H. et al. Evaluation of early clinical failure criteria for gram-negative bloodstream infections. Clin. Microbiol. Infect. 26, 73–77 (2020).
Battle, S. E. et al. Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection. Infection 47, 571–578 (2019).
Van Duin, D. et al. The Pitt bacteremia score predicts mortality in nonbacteremic infections. Clin. Infect. Dis. 70, 1826–1833 (2020).
Li, C. et al. Predictive value of a quick Pitt bacteremia score for prognosis of patients with bloodstream infection secondary to urinary tract infection: A retrospective cohort study. Infect. Drug Resist. Volume. 15, 4381–4391 (2022).
Vaquero-Herrero, M. P. et al. The Pitt bacteremia score, Charlson comorbidity index and chronic disease score are useful tools for the prediction of mortality in patients with Candida bloodstream infection. Mycoses 60, 676–685 (2017).
Spatola, L., Finazzi, S., Calvetta, A., Angelini, C. & Badalamenti, S. Subjective global Assessment–Dialysis malnutrition score and arteriovenous fistula outcome: A comparison with Charlson comorbidity index. J. Vasc. Access. 20, 70–78 (2018).
Aratani, T. et al. Association of methicillin resistance with mortality of hospital-acquired Staphylococcus aureus bacteremia. J. Int. Med. Res. 49, 1–12 (2021).
Yaw, L. K., Robinson, J. O. & Ho, K. M. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet. Infect. Dis. 14, 967–975 (2014).
Liang, K. H., Krus, D. J. & Webb, J. M. K-fold crossvalidation in canonical analysis. Multivar. Behav. Res. 30, 539–545 (1995).
Wang, S. et al. Development and validation of a nomogram prognostic model for SCLC patients. J. Thorac. Oncol. 13, 1338–1348 (2018).
Clinical and laboratory standards institute. M100-25 performance standards for antimicrobial susceptibility testing[S]. Wayne PA, UAS:CLSI, (2015).
Difazio, R. L., Strout, T. D., Vessey, J. A., Berry, J. G. & Whitney, D. G. Comparison of two modeling approaches for the identification of predictors of complications in children with cerebral palsy following spine surgery. BMC Med. Res. Methodol. 24, 236 (2024).
Kumar, R. & Indrayan, A. Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr 48, 277–287 (2011).
Paul, P., Pennell, M. L. & Lemeshow, S. Standardizing the power of the Hosmer–Lemeshow goodness of fit test in large data sets. Stat. Med. 32, 67–80 (2012).
Talluri, R. & Shete, S. Using the weighted area under the net benefit curve for decision curve analysis. BMC Med. Inf. Decis. Mak. 16, 94 (2016).
D’Hoore, W., Bouckaert, A. & Tilquin, C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 49(12), 1429–1433. https://doi.org/10.1016/s0895-4356(96)00271-5 (1996).
Jeon, M., Jang, S., Mun, S. J. & Kim, S. H. Thirty-Day mortality of persistent Methicillin-Resistant Staphylococcus aureus bacteremia: insights from a retrospective cohort study. Yonsei Med. J. 65, 770–776 (2024).
Russell, C. D. et al. Distinct clinical endpoints of Staphylococcus aureus bacteraemia complicate assessment of outcome. Clin. Infect. Dis. 79, 604–611 (2024).
Timbrook, T. T. et al. Procalcitonin and risk prediction for diagnosing bacteremia in hospitalized patients: A retrospective, National observational study. Diagnostics 13, 3174 (2023).
Moisa, E., Dutu, M., Corneci, D., Grintescu, I. M. & Negoita, S. Hematological parameters and procalcitonin as discriminants between bacterial Pneumonia-Induced sepsis and viral sepsis secondary to COVID-19: A retrospective Single-Center analysis. Int. J. Mol. Sci. 24, 5146 (2023).
Oussalah, A. et al. Usefulness of procalcitonin at admission as a risk-stratifying biomarker for 50-day in-hospital mortality among patients with community-acquired bloodstream infection: an observational cohort study. Biomark. Res. 11, 4 (2023).
Hindy, J. R., Quintero-Martinez, J. A., Lahr, B. D., DeSimone, D. C. & Baddour, L. M. Staphylococcus aureus bacteraemia and mortality: a population-based study in olmsted county, minnesota, from 2006 to 2020. Infect. Dis. 55, 1–8 (2022).
Vidal, P. M. et al. Differences between classical risk factors for infections caused by Methicillin-ResistantStaphylococcus aureus(MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the Staphylococcal cassette chromosomemectype IV MRSA strain. Infect. Control Hosp. Epidemiol. 30, 139–145 (2015).
Becker, K. et al. Characteristics of Staphylococcus aureus bacteraemia and predictors of early and late mortality. Plos One 12, e0170236 (2017).
